HIV-1 Vpr is targeted for degradation by autophagy
Autophagy is part of the innate immune arsenal to fight viruses, including HIV-1. We previously reported that HIV-1 Gag is targeted for autophagy-mediated degradation. Here, we identify HIV-1 Vpr, an important virulence factor, as an autophagy target in HIV-1 NL4-3, a lab adapted molecular clone. Notably, Vpr proteins from a collection of transmitted/founder viruses (TFVs) were resistant to autophagy. Based on this observation, we identified residues at positions 37, 45, 77, 83-86, 93-94 in NL4-3 Vpr as responsible for its susceptibility to autophagy. Importantly, differences between NL4-3 and TFV Vpr proteins at these positions impact their interaction with the autophagy receptors NDP52, SQSTM1/p62 and TAX1BP1. By engineering NL4-3 molecular clones harboring either autophagy-sensitive or -resistant vpr, we found that in 2D and 3D in vitro systems virus spread was significantly reduced for the virus carrying autophagy-sensitive Vpr. In conclusion, our study identifies Vpr as a novel autophagy target and suggests that Vpr susceptibility to autophagy impacts HIV-1 spread.
Authors
- Ruth Serra-Moreno (ORCID: https://orcid.org/0000-0002-1923-6414)
- Susanne Klute (ORCID: https://orcid.org/0000-0002-6592-8817)
- Konstantin M. J. Sparrer (ORCID: https://orcid.org/0000-0002-8682-1779)
- Yuexuan Chen
- Anju Bansal
Institutions
- Universität Ulm (DE)
- German Center for Neurodegenerative Diseases (DE)
- University of Rochester Medical Center (US)
- University of Alabama at Birmingham (US)
Publication Details
- Journal
- PLoS Pathogens
- Published
- 2026-03-02
- DOI
- https://doi.org/10.1371/journal.ppat.1014020
- Primary Topic
- Autophagy in Disease and Therapy
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Rochester
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung
- National Institutes of Health